Analysis of the National Hospital Discharge Survey data for 1988-1997 revealed a substantial disease burden associated with encephalitis in the United States: on average, there were nearly 19,000 hospitalizations (7.3 hospitalizations per 100,000 population), 230,000 hospital days, and 1400 deaths annually. For most encephalitis-associated hospitalizations (59.5%), the etiologic agent was unknown or not recorded; the most common etiologic categories among known causes were "viral" (38.2%) and "other infectious" (34.1%). The most common individual diagnoses with known agents were herpetic and toxoplasmic encephalitides (each associated with an annual average of 2100 hospitalizations). Human immunodeficiency virus infection was listed among discharge diagnoses for 15.6% of hospitalizations. Rates of encephalitis-associated hospitalization were highest for children !1 year old and persons у65 years old. The etiology of encephalitis was unknown for persons у65 years old significantly more often than it was for younger persons. The average cost of an encephalitisassociated hospitalization, as determined by the Healthcare Cost and Utilization Project for 1997, was $28,151, for an annual national cost of hospitalization of $650 million.
The clinical syndrome of acute encephalitis is associated with a number of infectious, postinfectious, and noninfectious causes [1] . Although 1100 different infectious pathogens and several toxins have been identified as causative agents of encephalitis [2] [3] [4] [5] [6] [7] [8] , in most cases, no pathogen can be detected [9, 10] . To better understand the etiologic agents associated with encephalitis and clarify its clinical and epidemiological features, the Emerging Infections Program coordinated by the Centers for Disease Control and Prevention (CDC) developed an enhanced surveillance program for encephalitis in California, New York, and Tennessee. Preliminary results of these surveillance studies indicated there was a substantial disease burden resulting from encephalitis, but incomplete case identification in defined populations precluded use of these data to estimate the rates of encephalitis. Similarly, previous population-based studies did not provide good estimates of the overall disease burden of encephalitis, because they either focused on specific pathogens or were conducted in small populations [4, 9, 11, 12] .
To better evaluate the burden of encephalitis in the United States, we analyzed data on hospitalizations for encephalitis from the National Hospital Discharge Survey (NHDS) and from the Nationwide Inpatient Sample of the Healthcare Cost and Utilization Project. The present study provides the first national estimate of the burden of encephalitis in the United States and demonstrates the substantial impact of this syndrome.
METHODS

Data sources.
Hospital discharge data for the 10-year period 1988-1997 were obtained from the NHDS through the National Center for Health Statistics, CDC (Atlanta, GA) [13] . The NHDS is a representative sample of patient discharge records from short-stay, nonfederal, general, and children's hospitals in the United States with discharge diagnoses coded according to the International Classification of Diseases, 9th Revision, Clinical Modification (ICD-9-CM) [14, 15] . Hospitalizations were weighted by use of National Center for Health Statistics procedures to obtain national estimates [13, 16] . Of note, the results based on the NHDS data are unreliable for estimates of !5000 hospitalizations and are to be used with caution for estimates of !9000 [17] . The cost of encephalitisassociated hospitalizations in the United States was estimated by use of the Nationwide Inpatient Sample data from the Healthcare Cost and Utilization Project, which includes the information on a sample (∼20%) of discharges from the community hospitals in the United States and also uses ICD-9-CM codes [15, 18] .
Definitions. An encephalitis-associated hospitalization was defined as a hospitalization for which at least 1 of the ICD-9-CM [15] codes for encephalitis was listed as a discharge diagnosis. Encephalitis was classified into the following etiologic categories: "viral," "other infectious," "postimmunization," "postinfectious," "toxic," "other specified," and "unexplained." A hospitalization associated with encephalitis of known cause was defined as one for which at least 1 cause-specific encephalitis code was listed among the discharge diagnoses. The ICD-9-CM codes for encephalitis included in the analysis are presented in table 1. A hospitalization for which any of the ICD-9-CM codes consistent with HIV infection [19] were listed was defined as associated with HIV infection. Before 1994, these codes included 042.0-044.9 ("HIV disease") and 795.8 ("positive serological or viral culture findings for HIV infection") and, since 1994, have included 042 ("HIV disease") and V08 ("asymptomatic HIV infection").
Data analysis.
Encephalitis-associated hospitalizations were analyzed according to etiologic category, year of discharge, patient's age and sex, standard census geographic region (Northeast, Midwest, South, or West) [20] , month of admission to the hospital, and duration of hospital stay. Because a high proportion (18.1%) of data on race was missing, no analysis by race/ethnicity was done [14, 21] . Encephalitis-associated hospitalizations were also examined according to the HIV infection status of patients.
Hospitalization rates for the groups of persons 14 years old were calculated by use of denominators derived from US census data [20] , whereas rates for children !1 year old were based on US natality data [22] . Rates were expressed as the estimated number of hospitalizations per 100,000 population. SUDAAN software (Research Triangle Institute) was used to calculate SEs for hospitalization estimates to account for the NHDS stratified sampling techniques used since 1988 [23] . SEs and 95% CIs were calculated for hospitalization rates by use of denominators obtained from vital records data that are considered to be free from sampling error [13, 20] . Comparisons were made according to demographic characteristics with use of 2-sided t tests with weighted variance estimates and SUDAAN software [23, 24] .
To estimate the cost of encephalitis-associated hospitalization in the United States, national costs for encephalitis-associated hospitalizations were calculated from the Healthcare Cost and Utilization Project Nationwide Inpatient Sample for 1997 [18] . Estimates of annual mean and median costs were weighted by means of Healthcare Cost and Utilization Project's weighting method, and the SD and quartiles were calculated by use of SUDAAN software [18, 23] . Estimates of the total national annual hospitalization cost was calculated by multiplying the mean cost by the estimated number of encephalitis-associated hospitalizations in 1997.
RESULTS
Etiologic categories.
From 1988 through 1997, encephalitis accounted for an estimated 186,804 hospitalizations (SE, ‫)284,01ע‬ in the United States (table 2) . On average, there were 18,680 encephalitis-associated hospitalizations each year, for an annual rate of 7.3 hospitalizations per 100,000 population (95% CI, 5.6-8.1). For most (59.5%) of these hospitalizations, no specific cause of encephalitis was noted (annual average, 11,108 hospitalizations; rate, 4.3 hospitalizations per 100,000 population; 95% CI, 3.7-5.0). Encephalitis with known causes accounted for an average of 7573 hospitalizations each year (rate, 3.0 hospitalizations per 100,000 population; 95% CI, 2.6-3.4).
Among hospitalizations associated with encephalitis of known cause, the most common etiologic category was "viral" (table 2), which accounted for 38.2% of such hospitalizations. Within this category, herpesvirus was the leading causative agent (21,507 hospitalizations; SE, ‫,)8472ע‬ followed by varicella (4759 hospitalizations; SE, ‫)9721ע‬ and arboviruses (3234 hospitalizations; SE, ‫.)2711ע‬ Codes for other known infectious causes were noted for 34.1% of hospitalizations associated with encephalitis of known cause. Toxoplasmic encephalitis accounted for the majority of discharge diagnoses in this category (21,504 hospitalizations; SE, ‫.)3852ע‬ Codes for other individual infectious causes (tuberculosis, meningococcal infection, syphilis, mumps, measles, poliomyelitis, rabies, and infection with Naegleria species) were noted in a small proportion (range, !0.01%-1.3%) of encephalitis-associated discharge diagnoses. Codes for postinfectious and other specified encephalitides were each noted in ∼13% of discharge diagnoses for hospitalizations associated with encephalitis of known cause, and the code for toxic encephalitis was noted for 2.2%. Codes for 11 etiologic category of encephalitis were noted in 0.4% of discharge records.
Hospitalizations by year, sex, age group, and geographic region. No distinct temporal trend was observed for encephalitis-associated hospitalizations in the United States during the study period (figure 1). Estimated numbers of hospitalizations per year ranged from 15,546 to 23,040 for all causes of encephalitis.
Annual rates of hospitalization for all causes of encephalitis combined were significantly higher for males than for females ( ) (table 3) . This difference between sexes was limited P ! .05 to hospitalizations for with encephalitis of known cause (P ! ); specifically, it was limited to hospitalizations for toxo-.001 plasmic encephalitis, 83.4% of which were of males ( ). P ! .001 Most (83.6%) of these patients were HIV-infected. In analyses conducted after excluding hospitalizations associated with HIV infection and toxoplasmic encephalitis, hospitalization rates for males and females were similar.
The age of patients ranged from !1 to 92 years (median, 39 years). Children !1 year old and persons у65 years old were at the highest risk of encephalitis-associated hospitalization, followed by persons 20-44 years old (table 3) . The patterns of encephalitis-associated hospitalization did not differ between unexplained encephalitis and encephalitis of known cause except for patients у65 years old. Persons у65 years old had a higher rate of hospitalization for unexplained encephalitis than they did for encephalitis of known cause (age-specific rates, 7.1 vs. 3.5 hospitalizations per 100,000 population; ) (table 3) . P ! .05 The only geographic difference in encephalitis-associated hospitalization rates was a significantly higher hospitalization rate for encephalitis of known cause in the Northeast (P ! ) (table 3) , which was attributed to a higher rate of toxo-.01 plasmic encephalitis in that region. After excluding cases of toxoplasmic encephalitis, the rates of encephalitis-associated hospitalization did not differ by geographic region.
Seasonal patterns. No clear seasonality was observed for hospitalizations associated with all causes of encephalitis, probably because the 2 subgroups (i.e., encephalitis of known cause and encephalitis of unknown cause) had complementary patterns of seasonal distribution. Hospitalizations without a known cause had a bimodal distribution of admissions, with higher numbers from June through October and in January and lower numbers in April and May. Hospital admissions for encephalitis of known cause tended to occur more frequently during the first 6 months of the year: 58.4% of hospitalizations that had an etiologic agent listed occurred during January-June, including 61.8% of hospitalizations for herpesvirus encephalitis and 93.2% of hospitalizations for encephalitis associated with varicella. Hospitalizations for toxoplasmic encephalitis occurred with nearly equal frequency throughout the year (51.5% occurred during the first 6 months of the year).
HIV infection. HIV infection was listed among the discharge diagnoses for 15.6% of encephalitis-associated hospitalizations (29,074; SE, ‫.)7633ע‬ Most hospitalizations (66.6%) in the HIV-infected group had toxoplasmic encephalitis listed as a discharge diagnosis, and most (90.4%) of toxoplasmic encephalitis-associated hospitalizations were of HIV-infected persons. The sex and age distribution of encephalitis among HIV-infected persons reflected epidemiological patterns of HIV infection in general: 84.9% of hospitalizations occurred among males, and 180% occurred among young adults (those 20-44 years old).
Hospital stay. Overall, during the study period, an estimated 2,298,209 hospital days (SE, ‫)683,951ע‬ were associated with all causes of encephalitis, for an average of ∼230,000 hospital days annually. The average hospital stay was 12 days (SE, ‫.)6.0ע‬ Of these hospital days, 1,079,419 (SE, ‫)816,87ע‬ were associated with unexplained encephalitis (annual average, 110,000), and 1,218,790 hospital days (SE, ‫)314,511ע‬ were associated with encephalitis of known cause (annual average, 120,000). Hospitalizations associated with encephalitis of known cause had significantly longer average duration (15.4 days; SE, ‫1.1ע‬ days) than did hospitalizations associated with unexplained encephalitis (9.7 days; SE, ‫;5.0ע‬
). For P ! .001 specific etiologies, the average duration of hospital stay was 15 days (SE, ‫)5.1ע‬ for encephalitis due to herpesvirus and 18.9 days (SE, ‫)3.2ע‬ for toxoplasmic encephalitis. The average duration of hospital stay for HIV-infected patients (17.5 days; SE, ‫)8.1ע‬ was significantly longer than that for patients without HIV infection (10.9 days; SE, ‫;6.0ע‬
). P ! .001 Hospitalization outcome. During the 10-year study period, a fatal outcome was recorded for an estimated 13,735 (SE, ‫)1091ע‬ encephalitis-associated hospitalizations (7.4%). The risk of a fatal outcome was ∼3.7-fold higher for the HIVinfected group (19.1% of hospitalizations; 5552 deaths; SE, ‫469ע‬ deaths) than for the group without HIV infection (5.2% of hospitalizations; 8183 deaths; SE, ‫8351ע‬ deaths). The proportion of encephalitis-associated hospitalizations with fatal outcome was 8.8% for the group with encephalitis of known cause (6672 deaths; SE, ‫,)119ע‬ and 6.4% for the group with unexplained encephalitis (7063 deaths; SE, ‫.)4251ע‬
Costs of encephalitis-associated hospitalizations. The mean estimated cost for an encephalitis-associated hospitalization in the United States for the most recent study year, 1997, was $28,151 (SE, ‫,)739$ע‬ and the median cost was $15,062. In 1997, the estimated number of encephalitis-associated hospitalizations in the United States was 23,040, for an estimated annual hospitalization cost of $650 million.
DISCUSSION
The results of the present study highlight a substantial disease burden associated with the clinical syndrome of encephalitis in the United States: on average, there were nearly 19,000 hospitalizations, 230,000 hospital days, and 1400 hospital deaths each year from 1988 through 1997, and the estimated hospitalization cost was $650 million for the most recent study year.
The true overall burden of encephalitis in the United States must be even greater, because our cost estimate includes the cost of the initial hospitalization only and not later rehabilitation, long-term care, and societal costs associated with the illness. It is likely that these costs are substantial, because many patients with encephalitis have significant residual damage [1] [2] [3] . Because the unit of analysis in NHDS is a hospital discharge and not a patient, it was impossible to account for repeated admissions and determine the exact number of cases of encephalitis that involved hospitalization. However, this limitation of the NHDS data should not have biased the estimate of overall burden of encephalitis-associated hospitalizations.
Overall, the rates of encephalitis-associated hospitalization remained stable, at 7.3 hospitalizations per 100,000 population, throughout the study period. This rate is very similar to the rate of 7.4 cases of encephalitis per 100,000 person-years reported in the study of CNS infections in Olmsted County, Minnesota, in the years 1950-1981 [9] ; it is much higher than the rates of 0.28-0.54 cases per 100,000 population reported by the CDC for the years 1988-1994 [25] , which were based on the passive reporting of cases of encephalitis to the CDC (a reporting system discontinued in 1994). Age-specific rates reported in our study were similar to those reported for similar age groups in other studies [26] [27] [28] .
Unexplained encephalitis was the most common etiologic category for encephalitis-associated hospitalizations in the United States. Encephalitis etiology remained unexplained among persons у65 years old significantly more often than it did among persons in younger age groups, but the reasons for this difference are not clear. A high proportion of encephalitis cases with no etiology identified (range, 48%-85%) has been reported in other studies [9, 10, 26, 28, 29] . Several factors probably contribute to the difficulties of identifying the etiology in individual cases of encephalitis, such as the limited availability of state-of-the-art laboratory techniques for identifying many pathogens, the lack of appropriate specimens, and our insufficient understanding of potential pathogens that cause encephalitis. In prospective studies of encephalitis, the etiology remained unknown for 48%-60% of cases, despite extensive testing for agents presently considered likely to cause this disease [10, 29] . However, it is likely that new agents will continue to be linked to encephalitis, as is exemplified by the recent identification of Nipah virus, Hendra virus, and enterovirus 71 as causes of encephalitis in several countries [30] [31] [32] [33] and West Nile virus in the United States, where it was recently introduced [34] .
No single agent was responsible for a large proportion of encephalitis cases. Among known pathogens, herpes simplex virus and Toxoplasma species were the most commonly identified causes of encephalitis, each accounting for 11.5% of all encephalitis-associated hospitalizations (on average, 2100 hospitalizations annually each). Herpes simplex virus has been known to be an important cause of encephalitis for some time [2] , and timely detection of infection with this virus is extremely important, because it can be treated effectively [2, 3] . The emergence of Toxoplasma gondii as a major causative agent in patients hospitalized with encephalitis in the United States is related to the HIV epidemic. CNS toxoplasmosis was noted as a complication of AIDS early during the epidemic [6, 35] , and toxoplasmosis of the brain is included among the AIDS-defining conditions listed by the CDC [36] . In our study, only a small proportion (!10%) of hospitalizations associated with toxoplasmic encephalitis occurred among patients without an associated diagnosis of HIV infection, and epidemiological characteristics of toxoplasmic encephalitis were largely determined by the presence of HIV infection. Varicella-zoster virus and arboviruses were among the more common causes of encephalitis (noted for 2.5% and 1.7% of all encephalitisassociated hospitalizations, respectively), but they still were responsible for small proportions of all encephalitis cases. These estimates of the number of hospitalizations for encephalitis associated with varicella and arboviruses are unreliable because of the small numbers involved.
The study demonstrated a substantial impact of the HIV epidemic on the encephalitis disease burden in the United States, especially on toxoplasmic encephalitis. Throughout the years 1988-1997, HIV infection was associated with a considerable proportion of encephalitis-associated hospitalizations. Because HIV-infected patients had longer the hospital stays and a substantially higher proportion of these patients died, the proportion of encephalitis disease burden associated with HIV infection is even higher. There are no ICD-9-CM codes for encephalitis caused by HIV infection per se. However, a high proportion of encephalitis-associated hospitalizations of HIVinfected persons were assigned agent-specific codes for encephalitis (most commonly, a code for Toxoplasma etiology). Therefore, primary HIV encephalitis is unlikely to account for a large proportion of hospitalizations in this group of patients.
One limitation of this type of study is our limited ability to look at the characteristics of patients with agent-specific diagnoses. Because the number of patients was small for most agent-specific diagnoses, and because the NHDS estimates based on small numbers of discharge records are unreliable [14, [16] [17] , we could not confidently analyze subgroups of patients with agent-specific diagnoses. In addition, there are no ICD-9-CM codes for encephalitis associated with such pathogens as enteroviruses, influenza and other respiratory viruses, Mycoplasma species, Bartonella species, and Rickettsia species, and Borellia burgdorferii. We could not separately analyze the data for different herpesviruses, because a single code (053.4) is assigned for all cases of herpetic encephalitis. These data sets are also limited by the lack of information about diagnostic criteria and by inconsistencies in coding and diagnostic practices between the sampled hospitals. Finally, NHDS does not include data on hospitalizations in federal facilities, such as the Indian Health Service facilities, and, therefore, its data are not representative of all hospitals in the United States. Despite these limitations, these data do provide the best available estimate of the number of encephalitisassociated hospitalizations in the United States. It is reassuring that these estimates are consistent with those from smaller studies in which diagnostic and coding practices were better controlled.
In summary, these data demonstrate that the disease burden associated with encephalitis in the United States is substantial. Our data also reiterate that, for the majority of encephalitis cases, the etiology remains unknown, and, therefore, approaches to prevention or treatment of most disease remain elusive. It is, however, worth noting that the 2 most common agent-specific diagnoses, encephalitis due to herpes simplex virus and due to Toxoplasma species, do provide treatment or prevention opportunities. It is likely that improvements in treatment of HIV infection will be associated with a decrease in the rate of HIV-associated encephalitis. Efforts to prevent and treat the majority of cases of encephalitis, however, must wait until the etiologic agents and risk factors associated with encephalitis are better characterized.
